Press monitoring
Credit: psdesign1 - Fotolia.com
mRNA skin cancer therapy halves risk of death in clinical trial
3.1.2024: Moderna has announced the results of a Phase 2b trial investigating its mRNA treatment for skin cancer, and it continues a streak of promising news. When paired with an immunotherapy, the treatment significantly reduced the risks of recurrence, metastasis and death compared to existing treatments alone, paving the way for trials against other cancers. Known as mRNA-4157 (V940), Moderna’s melanoma drug is an individualized neoantigen therapy.
News of Science
7.12.2015: Currently, we solve three main tasks using Arabidopsis thaliana as model: 1. Genetic determination of metabolome pathway connected to prenylflavonoid and lupulin production in hop. 2. Study of...
Newly on Gate2Biotech
14.3.2017: More than 400 decision makers and professionals attended PHARM Connect this year from over 25 countries with the same purpose: sharing their experiences, building new partnerships, finding the best...
International cooperation
3.5.2017: A Slovenian research institute developed protein patches applicable for healing chronic skin wounds rapidly and cost efficiently. Patches are biodegradable – disappearing in the wound, leaving no...
Students
11.8.2014: Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech industries, Pharma-Biotech Product and Company Valuation with Dr. Patrik Frei!
Jobs
- Department of Biochemistry, Cell and Molecular Biology, Charles University in Prague Project: Regulation of Beta-cell function and viability in relation to type 2 diabetes...
- Offer of topics for Ph.D. study projects in Third Faculty of Medicine, Charles University in Prague Project: Pancreatic beta-cell and pollutants: the effect of pollutants on viability and function of...
- “Postdoctoral position” at the Department of Cell Nucleus Plasticity The Institute of Experimental Medicine of the Czech Academy of Sciences, Department of the Cell...
Gate2Biotech - Biotechnology portal introduction
Having the status of the official portal for Czech biotechnology, Gate2Biotech serves to biotechnology companies, suppliers, investors, institutions, students and general public interested in biotechnology.
The portal is dedicated to the following subjects: plant and animal ...
- unites biotechnology community
- produces biotechnology report
- completes biotech database
- monitors latest news in biotechnology
- encourages innovative ideas
- searches investors
- facilitate worldwide awareness of biotechnology
